ArticleInternational journal of ophthalmology2025
Treatment results switching from aflibercept to bevacizumab in wet age-related macular degeneration.
Fabian KananenPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it